prostate-cancer

Documents about prostate-cancer

• Preference-based Comparative Study on Definitive Radiotherapy of Prostate Cancer With Protons#812126ClinicalTrials.gov
• Stereotactic MR-guided Adaptive Radiation Therapy for Localized Prostate Cancer#813197ClinicalTrials.gov
• Pre-Prostatectomy Celecoxib or Placebo#834288ClinicalTrials.gov
• 177Lu-EB-PSMA617 in Patients With Metastatic Castration-resistant Prostate Cancer#834928ClinicalTrials.gov
• Safety and Pharmacokinetics of ODM-204 in Patients With Metastatic Castration-Resistant Prostate Cancer#836079ClinicalTrials.gov
• Study of ORIC-944 in Patients With Metastatic Prostate Cancer#842407ClinicalTrials.gov
• Clinical Study Evaluating Targeted Biopsies and Cytological Imprints in Prostate Cancer#845410ClinicalTrials.gov
• PROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer Undergoing Active Surveillance#463751ClinicalTrials.gov
• Graph neural network-based risk stratification of prostate cancer using gene expression and SHAP interpretability#672172PLOS
• Study of 89Zr-DFO-MSTP2109A in Patients With Prostate Cancer#842122ClinicalTrials.gov
• Supportive Care Interventions and Quality of Life in Advanced Disease Prostate Cancer Survivors: An Integrative Review of the Literature#406805Scholar Commons
• Sequential Vaccinations in Prostate Cancer Patients#432884ClinicalTrials.gov
• Perineal Versus Rectal Approach for Prostate Biopsy to Prevent Iatrogenic Infections#230451ClinicalTrials.gov
• Biomarkers in Patients Undergoing Transrectal Ultrasound Prostate Biopsy#811416ClinicalTrials.gov
• Zanzalintinib in Men With Aggressive Variant Prostate Cancer#830156ClinicalTrials.gov
• Real-life PI-RADS score and biochemical recurrence after local treatment of prostate cancer in Afro-Caribbean men#156235HAL (France)
• Cancer statistics, 2022#6834OpenAlex
• Segmentation d'image échographique de la prostate assistée par Intelligence artificielle : définition de critères de qualité et réflexion sur la vérité terrain#246761HAL (France)
• High Resolution Diffusion Weighted Imaging in Prostate#833511ClinicalTrials.gov
• Enzalutamide and External Beam Hypofractionated Radiotherapy For Intermediate Risk Localized Prostate Cancer#803207ClinicalTrials.gov
• Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer#829466ClinicalTrials.gov
• Cancer statistics, 2024#7196OpenAlex
• A Pilot Trial of Interpersonal Psychotherapy for the Treatment of Depression in Patients With Prostate, Colorectal, Lung and Pancreatic Cancer#825749ClinicalTrials.gov
• Metronomic Oral Vinorelbine in Patients With Metastatic Tumors#829949ClinicalTrials.gov
• Efficacy of Massage for the Treatment of Cancer-Related Fatigue (CRF) in Prostate Cancer Survivors#841728ClinicalTrials.gov
• New compounds with potential application for prostate cancer treatment#281668RepOD Dataverse OAI Archive
• Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy#300318ClinicalTrials.gov
• Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer#383578ClinicalTrials.gov
• Exercise During Active Surveillance for Prostate Cancer#800540ClinicalTrials.gov
• Neoadjuvant Study of In-situ REIC/Dkk-3 in Prostate Cancer#806613ClinicalTrials.gov
• Hypofractionated Radiotherapy in Prostate Cancer Patients Aged 75 Years or Older.#811448ClinicalTrials.gov
• Evaluation of the Sentinel™ PCC4 Assay for Diagnosis, Prognosis and Monitoring of Prostate Cancer in Puerto Rico#813682ClinicalTrials.gov
• A Single-center Prospective Interventional Study on FPG500 in Non-metastatic Prostate Cancer Patients#825020ClinicalTrials.gov
• Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer#827553ClinicalTrials.gov
• Safety of LBH589 Alone and in Combination With IV Docetaxel and Prednisone#827876ClinicalTrials.gov
• Predictors of BCR After RARP for Localized Prostate Cancer: A Retrospective Analysis#828924ClinicalTrials.gov
• Radium-223 and Radiotherapy in Hormone-Naïve Men With Oligometastatic Prostate Cancer to Bone#831766ClinicalTrials.gov
• Dietary Fibre Supplementation to Delay Disease Progression in Early Prostate Cancer#841141ClinicalTrials.gov
• Darolutamide in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer#843973ClinicalTrials.gov
• Dual-tracer PET Radiomics for Prostate Cancer Stratification#845021ClinicalTrials.gov
• Kidney and gallbladder stones and the risk of prostate cancer: Results from the EPICAP study#147410HAL (France)
• N-803 Alone or in Combination With BN-Brachyury Vaccine or Bintrafusp Alfa (M7824) for Participants With Castration Resistant Prostate Cancer#343838ClinicalTrials.gov
• A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostate Cancer#369831ClinicalTrials.gov
• ADXS31-142 Alone and in Combination With Pembrolizumab (MK-3475) in Participants With Previously Treated Metastatic Castration-Resistant Prostate Cancer (mCRPC)#832811ClinicalTrials.gov
• Detection of Clinically Significant Prostate Cancer Using Transperineal Targeted Biopsy Compared to Standard Transrectal Biopsy#802851ClinicalTrials.gov
• The Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate Cancer#827612ClinicalTrials.gov
• Joint modelling of PSA dynamics and prostate cancer risks: A population-based study in men without prior prostate cancer#362521PLOS
• Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy.#311161ClinicalTrials.gov
• CyberKnife Radiosurgery for Locally Recurrent Prostate CA#802148ClinicalTrials.gov
• 177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer#349976ClinicalTrials.gov